MOH monthly performance report
Check MOH's monthly returns, drawdown, and seasonality trends — updated every month.
MOH monthly report
—
Key takeaways
- Molina Healthcare (MOH) closed September 2026 at $200.79, up 1.02% for the month and +11.73% over the trailing 12 months.
- Year-to-date, MOH is +15.70%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +12.10% versus its 200-day moving average ($179.11), a bullish technical signal.
- Over the past three years, MOH has underperformed the S&P 500 by −110.66%, with a relative strength index reading of 35.5.
- Win rate over the trailing 39 months stands at 48.7% — 19 positive months versus 20 negative months.
Molina Healthcare ended September 2026 at $200.79, posting a monthly return of +1.02%. The S&P 500 returned −0.70% over the same window, leaving relative performance at +1.72%.
The current quarter stands at −12.20% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +12.10% versus the 200-day moving average ($179.11).
Year-to-date, MOH is +15.70% against SPY +11.70%, a gap of +4.00%. The stock is currently −17.75% below its 52-week high, with maximum 3-year drawdown at −70.76%.
| Period | MOH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −2.10% | −0.12% | −1.98% |
| 1 Week | −1.68% | −0.34% | −1.34% |
| 1 Month | +1.02% | −0.70% | +1.72% |
| 3 Months | +0.29% | +2.80% | −2.51% |
| 6 Months | +34.58% | +13.85% | +20.73% |
| YTD | +15.70% | +11.70% | +4.00% |
| 12 Months | +11.73% | +15.01% | −3.28% |
| 3 Years | −38.97% | +71.69% | −110.66% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2026 | +46.00% |
| #2 | Jun 2026 | +31.74% |
| #3 | Dec 2025 | +17.05% |
| #4 | Jul 2024 | +14.79% |
| #5 | Aug 2025 | +14.54% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2025 | −47.01% |
| #2 | Oct 2025 | −20.01% |
| #3 | Apr 2024 | −16.73% |
| #4 | Jul 2026 | −14.46% |
| #5 | Feb 2026 | −14.22% |
| Quarter | Return |
|---|---|
| Q2 2025 | −9.56% |
| Q3 2025 | −35.76% |
| Q4 2025 | −9.31% |
| Q1 2026 | −23.19% |
| Q2 2026 | +71.57% |
| Q3 2026 (QTD) | −12.20% |
| Year | Return |
|---|---|
| 2023 | +9.41% |
| 2024 | −19.45% |
| 2025 | −40.37% |
| 2026 | +15.70% |
| Metric | Value |
|---|---|
| 52-Week High | $244.11 (2026-07-14) |
| 52-Week Low | $121.06 (2026-02-11) |
| Current Price | $200.79 |
| 200-Day Moving Average | $179.11 |
| Price vs 200DMA | +12.10% |
| 3-Year Maximum Drawdown | −70.76% (2026-02-11) |
| Current Drawdown from 52W High | −17.75% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 35.5 |
| 3-Year Excess Return vs S&P 500 | −110.66% |
| RS Peak | 112.9 (Oct 2023) |
| RS Trough | 23.9 (Feb 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MOH's return for this report period?
MOH returned +1.02% in the latest monthly window ending 2026-09-18.
Has MOH outperformed SPY year to date?
YTD MOH: +15.70% vs SPY: +11.70%.
What is MOH's 12-month return?
+11.73% over the trailing 12 months.
Is MOH above or below its 200-day moving average?
Price is +12.10% versus 200DMA ($179.11).
What is the maximum drawdown in the 3-year window?
−70.76% on 2026-02-11.